Robotic Gait Training for Parkinson's Disease
Trial Summary
What is the purpose of this trial?
The purpose of this study is to investigate the implementation of a novel gait rehabilitation stimulus (G-EO System) that could advance current clinical practices. The goal is to establish the safety and feasibility of gait training using the G-EO System as well as investigating the impact on mobility, function, quality of life, and participatory outcomes. Research Design: We propose a single-blinded, randomized trial of electromechanically-assisted gait training using the G-EO System in patients with Parkinson's disease with gait disability. Specific Aim 1 will establish the safety and feasibility of gait training using the G-EO System. Specific Aim 2 will determine the efficacy of gait training using the G-EO System for improving mobility, function, and quality of life
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that your Parkinson's medication has been stable for the past 3 months.
What data supports the effectiveness of the treatment Robotic Gait Training for Parkinson's Disease?
Research shows that robot-assisted gait training can improve certain aspects of walking in people with Parkinson's disease, such as hip movement, compared to traditional treadmill training. This suggests that robotic gait training may be effective in enhancing walking abilities in these patients.12345
Is robotic gait training generally safe for humans?
How is the G-EO End-Effector Gait Trainer treatment different from other treatments for Parkinson's disease?
The G-EO End-Effector Gait Trainer is unique because it uses robotic technology to assist with walking, helping to improve movement patterns by targeting both the mechanics and the nervous system involved in walking. This approach is different from traditional physical therapy as it combines robotic assistance with real-world training, potentially offering more effective rehabilitation for gait issues in Parkinson's disease.134510
Eligibility Criteria
This trial is for adults over 18 with Parkinson's Disease at stages 1-3, who've been stable on their current medication for the last three months. They must have a Mini Mental State Exam score above 24 and physician approval to exercise. Those with severe movement issues or recent physical therapy are excluded.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo electromechanically-assisted gait training using the G-EO System, administered 2 times per week for 40-60 minutes over six weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of walking speed, balance, and quality of life
Treatment Details
Interventions
- Conventional Physical Therapy Treatment
- G-EO End-Effector Gait Trainer
- Robotic Gait Rehabilitation
G-EO End-Effector Gait Trainer is already approved in Switzerland, European Union for the following indications:
- Neurological rehabilitation
- Orthopedic rehabilitation
- Gait disorders in Parkinson's disease
- Neurological rehabilitation
- Orthopedic rehabilitation
- Gait disorders in Parkinson's disease
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor